Direct ‐acting antivirals and hepatitis B virus (HBV) reactivation in co‐infected HBV/HCV kidney‐transplant recipients

ConclusionThese cases underline the discrepancies and highlight the need for comprehensive information before making definitive conclusions regarding the causal link between DAAs and HBV reactivation.This article is protected by copyright. All rights reserved.

Source: Transplant Infectious Disease - March 7, 2018 Category: Transplant Surgery Authors: Stanislas Pol, Olivier Marion, Ana ïs Vallet‐Pichard, Jean‐François Meritet, Karine Sauné, Laurent Alric, Nassim Kamar Tags: Short Communication Source Type: research